Ongoing Trials

In order to help vitiligo patients find and enroll in clinical trials, this page lists all clinical trials that are known to be open to vitiligo patients. Before enrolling in a clinical trial it is important to understand the potential risks and benefits, and to discuss your options with your dermatologist. 

There is a number of funded projects in Australia, Austria, Brazil, Canada, France, Netherlands, Spain, Taiwan, Thailand  that are currently looking for participants:

AUSTRIA

  • Epidermal Cell Transplantation in Vitiligo Skin With and Without Narrow-band Ultraviolet B (UVB) Treatment. By Medical University of Graz. This study is ongoing, but not recruiting participants. Start date: February 2008. External link

BELGIUM

  • Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Analysis). By University Hospital, Ghent. This study is currently recruiting participants. Start date: February 2010. External link

BRAZIL

  • Efficacy and Safety of ACH24 in the Treatment of Vitiligo. By Ache Laboratorios Farmaceuticos S.A. The recruitment status of this study is unknown. Start date: August 2011. External link.
  • Long-term Follow-up in Patients Affected With Acrofacial Vitiligo. By Irmandade da Santa Casa de Misericordia de Curitiba. The recruitment status of this study is unknown. Start date: August 2010. External link

CANADA

  • Efficacy and Safety of Intralesional Corticosterois in the Treatment of Vitiligo. By University of British Columbia. This study is currently recruiting participants. Start date: January 2013. External link
  • Efficacy of Red Light in Vitiligo. By University of British Columbia. This study is currently recruiting participants. Start date: February 2013. External link
  • Topical Psoralen Ultraviolet Light A Versus Narrow Band Ultraviolet Light B Treatment for Recalcitrant Dermatoses of the Hand. By The Skin Care Center, Vancouver General Hospital. This study is currently recruiting participants. Start date: February 2013. External link.
  • UVA 1 Phototherapy for Vitiligo. By The Skin Care Center, Vancouver General Hospital. This study is currently recruiting participants. Start date: February 2013. External link.

CZECH REPUBLIC

  • Investigation of 0.1% tacrolimus ointment for the treatment of vitiligo patients. By Avemedica, s.r.o. Ongoing. Start date: April 2006. External link.

CHINA

  • 308nm excimer laser + Betamethason Copound Injection vs. tacrolimus ointment + Betamethason Copound Injection for the treatment of advanced face and neck vitiligo: efficacy and safety of the multi-center, randomized, open, parallel, self-controlled clinical trials. By No. 1 Hospital of China Medical University. Recruiting status: Pending. Start date: October 2012. External link
  • 308nm excimer laser vs tacrolimus Secretary ointment for the treatment of the stationary phase surface neck vitiligo: the efficacy and safety of multi-center, randomized, open, parallel, self-controlled clinical trials. By No. 1 Hospital of China Medical University. Recruiting status:
    Pending. Start date: October 2012. External link
  • Dot matrix laser + Betamethason Copound Injection / Triamcinolone Acetonide + NB-UVB vs dipropionate betamethasone cream + NB-UVB for the treatment of the acral type (including the subcarinal parts) of vitiligo: the efficacy and safety of the multi-center, open, randomized controlled clinical trials. By No. 1 Hospital of China Medical University. Recruiting status: Pending. Start date: October 2012. External link
  • NB-UVB + lipoic acid tablets + Compound times betamethasone injection vs. NB-UVB + placebo + compound betamethasone injection for the treatment of sporadic progress vitiligo: efficacy and safety of the multi-center, randomized, double-blind, parallel-group clinical trial. By No. 1 Hospital of China Medical University. Recruiting status:Pending. Start date: October 2012. External link
  • NB-UVB + placebo vs. NB-UVB + lipoic acid tablets for the treatment of the sporadic treatment quiescent vitiligo: efficacy and safety of the multi-center, randomized, double-blind, parallel-group clinical trials. By The First Hospital of China Medical University. This study is currently receuiting participants. Start date: September 2012. External link  
  • Parallel-Controlled Clinical Study on Fill-fire Needle for Vitiligo. By Xinjiang Medical University Affiliated Hospital of Traditional Chinese Medicine. Recruiting status:Pending. Start date: January 2014. External link

FRANCE

  • Exploratory Study To Evaluate the Safety and Efficacy of CD07387 Solution In Patients With Vitiligo. By Galderma R&D. Recruiting patients. Start Date: February 2010. External Link
  • Maintenance Treatment of Non Segmental Vitiligo With Tacrolimus Ointment 0.1% Versus Control. By CHU de Nice - Hôpital de l'Archet and by CHU de Bordeaux. This study is currently recruiting participants. Start date: March 2012. External link.

INDIA

  • Pharmaceutical standardization of two different dosage form of Apamarg Kshara Yoga and Their clinical efficacy on Shvitra (vitiligo). By Department of RS BK I P G T and R A Gujarat Ayurved University. Not yet recruiting patients. Start date: November 2012. External link
  • A multicentric single blind, randomized, parallel group, comparative study to compare the efficacy and safety of Coded Unani formulations UNIM 001+UNIM003 with Psoralen in the treatment of Bars (vitiligo). By Central Council for Research in Unani Medicine CCRUM New Delhi. Open to Recruitment. Start date: Decembr 2013. External link
  • A randomized comparative study of the effect of betamethasone oral mini-pulse therapy and oral azathioprine in progressive non-segmental vitiligo. By AIIMS, New Delhi. Open to Recruitment. Start date: October, 2013. External link

ITALY

  • Efficacy of Autologous Outer-Root-Sheath Melanocytes Transplantation in the Treatment of Vitiligo. By Papa Giovanni XXIII Hospital and by Spedali Civili. This study is currently recruiting participants. Start date: August 2013. External link.

IRAN

  • Comparative efficacy of 0.1%Tacrolimus ointment versus 0.005% Calcipotriol ointment in perifollicular pigmentation in patients with hand and facial vitiligo. By Sina Hospital. Recruiting. Start date: June 2012. External link
  • Comparative evaluation of efficacy of dermabrasion alone, injection of melanocyte suspension and autologous melanocyte suspension transfer in the treatment of vitiligo. By Clinics of Skin and Stem cell Research Center of Tehran University of Medical Sciences. Recruiting. Start date: June 2012. External link.
  • Evaluation of efficacy of microdermabrasion in association with Tacrolimus ointment plus Elocome ointment in compare with pimecrolimus ointment plus Elocome oint in patients with vitiligo. By Skin clinic of Imam Khomeini hospital. Recruiting. Start date: August 2013. External link.
  • NBUVB versus minocycline in vitiligo stabiling in unstable vitiligo. By Alzahra hospital, Isfahan, Islamic Republic Of Iran. Recruitment complete. Start date: July 2012. External link

JAPAN

  • Clinical trial for development of topical rapamycin treatment for white macules due to tuberous sclerosis complex, vitiligo vulgaris, and other congenital diseases. By Department of Dermatology Graduate School of Medicine, Osaka University. Recruitment status: enrolling by invitation. Start date: August 2011. External link
  • Evaluation of effectiveness of smashed skin grafting therapy for vitiligo vulgaris. By Department of Dermatology Graduate School of Medicine, Tohoku University. Recruitment status: enrolling by invitation. Start date: October 2013. External link 

NETHERLANDS

  • Autologous Cell Suspension Grafting Using ReCell in Vitiligo and Piebaldism Patients. By The Netherlands Institute for pigment disorders, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA). This study is ongoing, but not recruiting participants. Start date: July 2012. External link
  • Narrow band UV-B phototherapy and fluticasone proprionate versus narrow band UV-B phototherapy and placebo for the treatment of active vitiligo: a randomized double blind controlled trial. By Academic Medical Center. Recruiting patients. Start date: July 2009. External link
  • Punchgrafting Techniques for Vitiligo (MiniSNIP). By Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA). The recruitment status of this study is unknown. Start date: June 2011. External link

SAUDI ARABIA

  • Oral Ginkgo Biloba and Narrow Band UVB in the Treatment of Vitiligo (GB). By King Saud University. The recruitment status of this study is unknown. Start date: November 2009. External link

SPAIN

  • Ensayo clínico fase I-II, controlado intraindividualmente para evaluar la eficacia del trasplante de melanocitos autólogos en monocapa sobre un soporte de membrana amniótica en el tratamiento del vitíligo estable. By Instituto Científico y Tecnológico de Navarra. Recruiting patients. Start date: November 2010. External link
TAIWAN
  • The Mechanism of Melanocyte Self-Assembly on Biomaterials and the Functional Analysis. By National Taiwan University Hospital. This study is currently recruiting participants. Start date: May 2006. External link

THAILAND

  • Comparison of Efficacy and Safety of 0.1% Tacrolimus and 0.1% Mometasone Furoate for Adult Vitiligo. By Department of Dermatology, Faculty of Medicine, Siriraj Hospital, Bangkok, Thailand. Start date: June 2009. This study is ongoing, but not recruiting participants. External link

USA

  • The Efficacy of Hand NBUVB Versus Excilite Treatment in Vitiligo After Minigrafting on the Dorsal Hands. By University of Texas Southwestern Medical Center. The recruitment status of this study is unknown. Start date: January 2008. External link
  • Clinical Trial of Simvastatin to Treat Generalized Vitiligo. By University of Massachusetts, Worcester (USA). Start date: January 2012. This study is ongoing, but not recruiting participants.   External link
  • NB-UVB and PUVA Vitiligo Study. By Henry Ford Health System. This study is currently recruiting participants. Start date: November 2012. External link 
  • Photocil (Topical) for the Treatment of Vitiligo. By Applied Biology, Inc. This study is currently recruiting participants. Start date: November 2013. External link
  • Prospective Open Label Parallel Study Comparing Use of Carbon Dioxide Laser Versus Dermabrasion for Denuding Epithelium and Collagen Dressing Versus Vaseline Impregnated Gauze for the Melanocyte Keratinocyte Transplant Procedure. By Henry Ford Health System. This study is currently recruiting participants. Start date: January 2014. External link
  • Questionnaire and Laboratory Data on Vitiligo Vulgaris. By St. Luke's-Roosevelt Hospital Center (USA). Start date: September 2010. The recruitment status of this study is unknown. External link

Last update: February 6, 2014.

The VR Foundation cannot guarantee the completeness of this list of clinical trials. It does not contain all clinical studies conducted in the United States and elsewhere because not all studies are required by law to be registered.

For more information about clinical trials that you might be eligible for, please consult with your dermatologist. Please contact us if you are aware of additional clinical trials open to vitiligo patients.

.

PAST TRIALS

Vitiligo Clinical Trials enrollment, by year:

2008 - 35 trials - Average patients recruited: 276
2009 - 37 trials - Average patients recruited: 327
2010 - 34 trials - Average patients recruited: 315
2011 - 35 trials - Average patients recruited: 439
2012 - 35 trials - Average patients recruited: 501

Why Clinical Trials?

New to clinical trials entirely? Have you tried but it did not work for you? Continue reading »

image description

I support the petition to designate June 25 as Vitiligo World Day and save millions of people worldwide from social isolation and persecution.

Terms of Use Privacy Statement

To download this free file, please tell us a little bit about yourself.

Close